This article will highlight some of the steps you can take to implement lessons learned and optimize your company’s policies and procedures in terms of compliance and alignment with the regulations . Different regulatory agencies...
What's wrong with this picture? On a typical workday, you may see nothing wrong with this picture...but place an FDA Investigator or other regulatory Inspector in this room, and you may it see differently. I’ve had the opportunity to work as an FDA Investigator...
The first thought that typically comes to mind when you hear about an upcoming FDA inspection at your site is the logistics-- where to meet, document review, and your facility’s condition. There are however, other factors to keep in mind for both on-site and...
An often-overlooked aspect of a clinical research study is the Trial Master File (TMF). As the backbone of every trial, the TMF houses all of the documentation describing all study activity in compliance with Good Clinical Practice (GCP) guidelines and approved protocols. With all of the moving parts involved in and outside of the TMF, it can be a constant challenge
Tackling the Trial Master File (TMF) can seem daunting at times. With so many moving parts and documents, it can get more difficult to manage as a clinical trial continually progresses. However, the TMF is essential as...
Correspondence in the Trial Master File (TMF) is imperative to keep all parties abreast of the details involved. In order to keep all information relevant and the entire TMF streamlined and efficient, it is necessary to decide what is important, applicable, and...
The Trial Master File (TMF) stores all essential documents pertaining to the conduct of a clinical trial in compliance with Good Clinical Practice (GCP) guidelines. It is the “backbone” that tells the story of a clinical trial at every phase from start-up to...
There has never been a better time to be in clinical research. From constant scientific innovation to being a part of a community of academic experts, there are seemingly endless opportunities to grow. While it all might seem exciting from the outside, organizations...
An FDA inspection can be triggered by a variety of factors with submission of an application for product approval as one of the most popular factors. With the increasing need to outsource to clinical research vendors, inspections of sponsor companies tend to focus...
A corrective and preventive action (CAPA) plan is a set of steps done to address a compliance problem and, more significantly, to keep it from happening again. The immediate noncompliance and the broader nature of the problem will be the subject of a CAPA plan. It...
Since the year 2010, the most prevalent FDA audited observations in the medical device business have been “insufficient corrective and preventative action procedures.” Its recurrence as the most common issue year after year indicates that many device firms have...
I have been asked so many questions about my FDA career and what it was like working with the FDA. I thought it would be best to write about my experience in an interview-based article according to the most frequently asked questions. How were you introduced to the...
ICH E6 (R3) Guidelines for Good Clinical Practices (GCP) have been a work in progress to put forward changes to the previous R2 version. The overall purpose is to revise principles that account for ethical trial conduct, participant safety, and clinical trial...
The coordinated and impartial review of all clinical trial-related activities and records is known as quality assurance. In the case of a clinical study, the quality assurance department has a wide range of responsibilities. Quality Assurance (QA) departments...
The concept of pharmacovigilance—derived from the Greek and Latin 'Pharmakon' (medicinal substance) and Vigilia (to keep watch)—emerged in earnest among physicians and other health experts almost 200 years ago. Initially, the practice amounted primarily to letters and...
SOPs are crucial for ensuring compliance and conducting clinical trials. SOPs provide a standardized approach to clinical research processes, which is essential for maintaining consistency and quality across all study sites and participants. The lack of SOPs may...
The Delegation of Authority (DOA) log is a document that records the delegation of authority for various tasks and decisions related to the conduct of a clinical trial and constitutes a critical facet of clinical trial management of participating clinical sites. The...
The Trial Master File (TMF) is the backbone of the clinical trial. It consists of essential documents which not only enable the conduct of a clinical trial, but also enable the evaluation of the quality of data produced. One of the questions asked at the beginning of...
A quality culture pertains to the shared beliefs, values, and attitudes that incorporates a quality mindset which also influences the actions taken by individuals within an organization. It is essential to establish a quality culture in the workplace in clinical...
In the rapidly evolving landscape of healthcare and pharmaceuticals, sponsor companies face the critical challenge of ensuring that their vendor practices align seamlessly with FDA requirements. This alignment is not just a regulatory mandate but a cornerstone for...
Clinical site management is a pivotal aspect of clinical research, ensuring the integrity, safety, and efficacy of trials. Adherence to Good Clinical Practice (GCP) is non-negotiable, demanding meticulous attention and robust strategies. By elevating site management...
FDA inspections are a critical aspect of clinical research, ensuring adherence to GCP standards and safeguarding participant well-being. Our comprehensive guide is designed to empower your clinical site to navigate these inspections successfully, transforming...
FDA inspections, while critical for ensuring the safety and efficacy of clinical research, can be a significant source of stress for clinical site staff. The anticipation and the process itself can create anxiety, but with the right strategies, your team can navigate...
Having a complete Trial Master File (TMF) is the highest priority for sponsors in terms of providing an accurate picture of the affiliated clinical trial. This article speaks about key aspects and techniques to implement in order to have an inspection-ready TMF. Key...
By Afifa F. - 2K Clinical Consulting, Inc. There is a popular saying in quality management that if you do not have the process written down, then it probably didn't happen. Just like any other business, Clinical trials must have a management system as well. This...
The protocol for a clinical trial describes the entire study in detail, including the operational details of how it should be carried out. The purpose of the study protocol is to protect the health and safety of study participants while also proving efficacy of the...
You have just undergone an audit and discovered a gap in your process. What’s the next step? The key to inspection readiness is having an effective CAPA system that not only correct the issues but also prevent them from happening again. Only by identifying the root...
The national and global regulations for conducting clinical trials involving human participants are known as Good Clinical Practice (ICH-GCP). They include not only quality criteria, but also regulatory guidelines to ensure that all newly created pharmaceuticals and...
Lack of consistent, clear, and adequate source documentation is one of the most typical inspection results in investigator site inspections. This is also the most discovered flaw during sponsor audits. To guarantee that the study results are established on the...
“We are constantly working towards the highest level of compliance possible.” - Mike Davidson In clinical research, compliance is essential to ensuring that the research trial is conducted safely and accurately. The ability to maintain the highest level of compliance...
The selection of the appropriate research participants is critical to the success of any clinical trial. Regrettably, the majority of clinical trials done are severely lacking in diversity. All too frequently, cultural and genetic factors unique to Asians,...
One of the primary goals of every clinical trial is to evaluate an intervention's safety and effectiveness to that of a control or other care. As a result, all studies expose participants to risk, and these are risks that may be similar to those they encounter in...
As part of a sponsor’s inspection readiness activities, storyboarding is a crucial step that provides a solid framework for addressing challenging or important areas of noncompliance via corrective and preventive actions. With the aid of organizational and risk...
Recently approved medications and those already on the market can benefit from pharmacovigilance to help ensure patient safety. While pharmacovigilance practices are highly regulated in the context of clinical trials, post-marketing incidence reporting is not properly...
The Benefits & How to Utilize Them Checklists are invaluable tools in Inspection Readiness programs within regulated industry of pharmaceutical, medical device and biotech companies. They provide a structured approach to ensure that all necessary preparations are...
The task of documenting and maintaining records can prove to be a daunting one in the world of clinical research. Effective resource allocation constitutes a delicate equilibrium. Striking the right balance between dedicating resources to training and compliance...
World Quality Day, celebrated on a global scale every year on the second Thursday in November, serves as a reminder that quality is not just a buzzword or a department in your organization—it's everyone's business. Whether you work in clinical operations, healthcare,...
As we navigate through the new year of 2024, the clinical trial landscape is experiencing transformative changes, particularly in the aspect of inspection-readiness. This abbreviated article provides a focused look into how these changes are influencing trial...
The year 2024 has brought significant innovations to the clinical trial sector, especially in terms of inspection-readiness. This article provides an overview of how these trends are influencing preparedness for regulatory inspections. For a deeper understanding of...
In the constantly shifting terrain of regulatory compliance, mastering inspection readiness is more crucial than ever. Central to this challenge is developing and implementing a robust Inspection Readiness Plan (IRP). This plan isn't just a procedural necessity; it’s...
In this article, we delve into the intricacies of the evolving landscape of clinical research in 2024 with Artificial Intelligence (AI), Decentralized Clinical Trials (DCTs), and regulatory compliance. The AI Revolution in Clinical Research Artificial Intelligence...
In an era where vendor partnerships are integral to business success, understanding the nuances of vendor auditing is crucial. This guide aims to empower our free subscribers with foundational knowledge and actionable insights to elevate your vendor auditing...
In the realm of clinical research, the selection and management of vendors are pivotal to the success and integrity of clinical trials. Adhering to Good Clinical Practice (GCP) guidelines, a cornerstone in ensuring the ethical and scientific quality of clinical...
Inspection readiness often looks effortless from the outside. A clean TMF.Confident site staff.Minimal findings.A smooth inspection close-out. When an FDA or regulatory inspection goes well, it’s easy to assume the organization was simply “always inspection-ready.”...
Audit readiness isn’t an event—it’s a habit.For Clinical Research Associates (CRAs), juggling competing timelines and complex protocols, that mindset is everything. Being inspection-ready doesn’t begin when the FDA calls. It’s built visit by visit, query by query, and...
In today’s fast-paced regulatory landscape, being inspection-ready isn’t optional—it’s essential. A strong Root Cause Analysis (RCA) process can mean the difference between repeat deviations and long-term excellence. RCA is more than just a quality requirement—it's...
When the FDA comes knocking, two issues often top the list of inspection findings: lack of Principal Investigator (PI) oversight and failure to follow the protocol. These aren't minor slip-ups. They can delay a study, jeopardize data integrity, or even halt your...
Clinical trials drive medical advancements by developing safe and effective treatments. However, a major issue threatens their reliability—lack of diversity. When trials exclude participants from different racial, ethnic, and socioeconomic backgrounds, the data does...
FDA inspections are critical moments that can define the reputation and operational success of clinical research sites. While these inspections can be a source of stress, with the right strategies and a proactive mindset, they can transform into opportunities for...
Continuous Quality Improvement (CQI) is essential in clinical research, impacting both data integrity and participant safety. By incorporating CQI throughout the clinical trial process, research teams can consistently meet and even exceed regulatory standards. This...
Proper documentation is critical for passing FDA GCP inspections. It demonstrates compliance with regulatory requirements while ensuring clinical trials are conducted with the highest level of accuracy, integrity, and transparency. For any clinical research site,...